Long Covid: Chronic Fatigue Surge
- BERLIN (AP) — The number of individuals grappling with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has likely doubled, according to Carmen scheibenbogen, director of the Charité fatigue Centrum in...
- Health insurance companies and specialist societies estimate that approximately 600,000 people are currently affected by ME/CFS.
- Around 200 international medical professionals are participating in the conference, which is dedicated to exploring care strategies and medication research.
ME/CFS Cases Likely Doubled Amid Pandemic, Experts Say
Table of Contents
- ME/CFS Cases Likely Doubled Amid Pandemic, Experts Say
- International Conference Focuses on care, Medication
- ME/CFS: A Chronic and Debilitating Condition
- Government Acknowledges Data Gaps on Long COVID
- ME/CFS: Your Questions answered by an Expert
- What is ME/CFS?
- What are the main symptoms of ME/CFS?
- How long do symptoms need to last to be diagnosed with ME/CFS?
- How common is ME/CFS?
- Why is ME/CFS getting more attention now?
- Can ME/CFS be caused by COVID-19?
- Is there a cure for ME/CFS?
- Are there any treatments for ME/CFS?
- What challenges do ME/CFS patients face?
- What is the German Federal Government doing about ME/CFS and Long COVID?
- Where can I find further information about ME/CFS and the latest findings?
- Conference Highlights: Key Takeaways
- Summary of Key Facts:
BERLIN (AP) — The number of individuals grappling with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) has likely doubled, according to Carmen scheibenbogen, director of the Charité fatigue Centrum in Berlin. Scheibenbogen’s remarks preceded a two-day specialist conference held in Berlin focusing on the condition.
Health insurance companies and specialist societies estimate that approximately 600,000 people are currently affected by ME/CFS.
International Conference Focuses on care, Medication
Around 200 international medical professionals are participating in the conference, which is dedicated to exploring care strategies and medication research. Discussions are slated to continue through tuesday.
Scheibenbogen emphasized the critical need to address the inadequate care and lack of effective treatments for both ME/CFS and Long COVID patients, despite recent progress in the field. “Treatment options remain limited,” she stated. “ME/CFS has historically received insufficient attention in medical education, leading to a notable demand for further training.”
ME/CFS: A Chronic and Debilitating Condition
ME/CFS is a chronic, debilitating disease characterized by persistent symptoms such as profound exhaustion, cognitive dysfunction, and sleep disturbances lasting at least six months. A hallmark of the condition is the exacerbation of symptoms following physical or mental exertion.
While currently incurable, ME/CFS has gained increased recognition due to the coronavirus pandemic and the ongoing discussion surrounding the long-term consequences of COVID-19 (Long COVID), as ME/CFS can sometimes manifest following a viral infection. Experts note it can be the most severe form of long COVID. however, a ample number of individuals were affected by ME/CFS prior to the pandemic.
Government Acknowledges Data Gaps on Long COVID
In October 2024, the German Federal Government acknowledged that existing statistics do not provide a complete understanding of the prevalence of Long COVID.Estimates suggest that the number of affected individuals coudl reach six figures.
ME/CFS: Your Questions answered by an Expert
This article provides facts on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) based on the latest news and expert opinions. The goal is to provide you with clear, helpful, and accurate answers, presented in a user-friendly Q&A format.
What is ME/CFS?
ME/CFS, also known as myalgic encephalomyelitis/chronic fatigue syndrome, is a chronic and debilitating disease. It is characterized by persistent symptoms that can substantially impact a person’s quality of life.
What are the main symptoms of ME/CFS?
The core symptoms of ME/CFS include:
Profound exhaustion: This fatigue is not relieved by rest.
Cognitive dysfunction: This can manifest as difficulty with memory, concentration, and processing information.
Sleep disturbances: This can include insomnia or unrefreshing sleep.
Post-exertional malaise (PEM): This is a hallmark symptom where physical or mental exertion leads to a worsening of symptoms.
How long do symptoms need to last to be diagnosed with ME/CFS?
Symptoms of ME/CFS must persist for at least six months for a diagnosis to be considered.
How common is ME/CFS?
Recent estimates suggest that the prevalence of ME/CFS is increasing. According to Carmen Scheibenbogen, director of the Charité Fatigue Centrum in Berlin, the number of individuals with ME/CFS has likely doubled. Health insurance companies and specialist societies estimate that approximately 600,000 peopel are currently affected.
Why is ME/CFS getting more attention now?
The coronavirus pandemic and the emergence of Long COVID have brought increased recognition to ME/CFS. Experts note that ME/CFS can sometimes manifest following a viral infection.Notably, ME/CFS can be the most severe form of Long COVID.
Can ME/CFS be caused by COVID-19?
Yes, ME/CFS can sometimes manifest following a viral infection, including COVID-19.
Is there a cure for ME/CFS?
Currently, there is no known cure for ME/CFS.
Are there any treatments for ME/CFS?
treatment options for ME/CFS remain limited.However, research continues to explore new strategies and medications. A specialist conference held in Berlin is dedicated to exploring care strategies and medication research.
What challenges do ME/CFS patients face?
Patients with ME/CFS face significant challenges, including:
Inadequate care: Patients often struggle to receive appropriate medical attention.
Lack of effective treatments: Limited treatment options means managing symptoms is a primary focus.
* insufficient attention from the medical community: There is a notable demand for further training among medical professionals.
What is the German Federal Government doing about ME/CFS and Long COVID?
In October 2024, the German Federal Government acknowledged that existing statistics do not provide a complete understanding of the prevalence of Long COVID. Estimates suggest that the number of affected individuals could reach six figures. More research and data collection are needed to fully understand the impact of Long COVID along with related conditions like ME/CFS.
Where can I find further information about ME/CFS and the latest findings?
For the latest research and news, consult these sources:
- Specialist conferences: Events like the one in Berlin bring together experts.
- Medical Research Journals: Journals publish the latest research on ME/CFS.
- Patient advocacy groups: organizations dedicated to ME/CFS offer resources, support, and updated information.
Conference Highlights: Key Takeaways
A key takeaway from the specialist conference in Berlin is the emphasis on care strategies and medication research. The conference highlighted the need to address the challenges ME/CFS patients face. Discussions continue through Tuesday.
Summary of Key Facts:
Here’s a quick summary to help you understand the core information:
| Aspect | Details |
|---|---|
| Definition | Chronic, debilitating disease |
| Key Symptoms | Profound exhaustion, cognitive dysfunction, sleep disturbances, PEM |
| affected Individuals | Approximately 600,000 currently, likely doubled due to pandemic |
| Main Concern | Inadequate care and limited treatments |
| Importance | Increased concern due to the overlap with Long COVID |
| Ongoing Research | Focused on care strategies and medication research |